1. Brue T, Delemer B. Diagnosis and management of hyperprolactinemia: expert consensus-French Society of Endocrinology. Ann Endocrinol (Paris). 2007 Feb;68(1):58-64. PubMed | Google Scholar

  2. P G Crosignani. Management of hyperprolactinemia in infertility. J Reprod Med. 1999 Dec;44(12 Suppl):1116-20. PubMed | Google Scholar

  3. Colao A, Sarno AD, Cappabianca P, Briganti F, Pivonello R, Somma CD et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol. 2003 Mar;148(3):325-31. PubMed | Google Scholar

  4. Colao A, Savastano S. Medical treatment of prolactinomas. Nat Rev Endocrinol. 2011 May;7(5):267-78. PubMed | Google Scholar

  5. Wang AT, Mullan RJ, Lane MA, Hazem A, Prasad C, Gathaiya NW et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev. 2012 Jul 24;1:33. PubMed | Google Scholar

  6. Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab. 1985 Apr;60(4):698-705. PubMed | Google Scholar

  7. WHO. Global prevalence of infertility, infecundity and childlessness. Accessed on 23rd Dec 2016.

  8. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys. PLoS Med. 2012;9(12):e1001356. PubMed | Google Scholar

  9. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006 Aug; 65(2):265-73. PubMed | Google Scholar

  10. Saejong R, Dangrat C, Techatrisak K, Angsuwatthana S, Rattanachaiyanont M, Tanmahasamut P. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital. J Med Assoc Thai. 2013 Oct;96(10):1247-56. PubMed | Google Scholar